Search

Search Constraints

You searched for: Author/Creator Svane, I M

Search Results

1. 111P Pilot study on the feasibility, safety and immunogenicity of a personalized neoantigen-targeted immunotherapy (NeoPepVac) in combination with anti-PD-1 or anti-PD-L1 in advanced solid tumors. (15th December 2019)

2. 1132PDClinical efficacy of T-cell therapy after short-term BRAF-inhibitor induction in checkpoint inhibitor resistant metastatic melanoma patients. (23rd October 2018)

5. 39P TCR engaging antigen-scaffolds for targeted expansion of functionally improved T cells for adoptive cell therapy. (15th December 2019)

6. Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma. (28th March 2019)

7. T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression. (24th April 2018)